These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32795310)

  • 1. Effects of canola or olive oil on plasma lipids, lipoprotein-associated phospholipase A
    Khandouzi N; Zahedmehr A; Nasrollahzadeh J
    Lipids Health Dis; 2020 Aug; 19(1):183. PubMed ID: 32795310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of canola and olive oils consumption compared to sunflower oil, on lipid profile and hepatic steatosis in women with polycystic ovarian syndrome: a randomized controlled trial.
    Yahay M; Heidari Z; Allameh Z; Amani R
    Lipids Health Dis; 2021 Jan; 20(1):7. PubMed ID: 33514384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of canola oil and olive oil consumption on the serum lipid profile in adults: a systematic review and meta-analysis of randomized controlled trials.
    Pourrajab B; Sharifi-Zahabi E; Soltani S; Shahinfar H; Shidfar F
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):12270-12284. PubMed ID: 35866510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polyphenol-rich extra-virgin olive oil on lipid profile and inflammatory biomarkers in patients undergoing coronary angiography: a randomised, controlled, clinical trial.
    Khandouzi N; Zahedmehr A; Nasrollahzadeh J
    Int J Food Sci Nutr; 2021 Jun; 72(4):548-558. PubMed ID: 33121297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
    Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
    Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study.
    Liu X; Zhou W; Fan W; Li A; Pang J; Chen Z; Li X; Hu X; Zeng Y; Tang L
    BMC Cardiovasc Disord; 2022 Apr; 22(1):177. PubMed ID: 35430800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated circulating levels of lipoprotein-associated phospholipase A2 in obese children.
    Sakka S; Siahanidou T; Voyatzis C; Pervanidou P; Kaminioti C; Lazopoulou N; Kanaka-Gantenbein C; Chrousos GP; Papassotiriou I
    Clin Chem Lab Med; 2015 Jun; 53(7):1119-25. PubMed ID: 25581763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Plasma Lipoprotein-Associated Phospholipase A2 Concentrations and Apolipoprotein in Stable Coronary Artery Disease Patients.
    Ling Y; Tang S; Cao Y; Fu C
    Dis Markers; 2020; 2020():8818358. PubMed ID: 33029257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].
    Chen J; Cai HW; Miao J; Xu XM; Mao W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
    Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lp-PLA2: inflammatory biomarker of vascular risk in multiple sclerosis.
    Sternberg Z; Drake A; Sternberg DS; Benedict RH; Li F; Hojnacki D; Weinstock-Guttmann B; Munschauer FE
    J Clin Immunol; 2012 Jun; 32(3):497-504. PubMed ID: 22246459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
    Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
    BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients.
    Raichlin E; McConnell JP; Bae JH; Kremers WK; Lerman A; Frantz RP
    Transplantation; 2008 Apr; 85(7):963-8. PubMed ID: 18408575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male Asian Indians with nonalcoholic fatty liver disease.
    Nigam P; Bhatt S; Misra A; Chadha DS; Vaidya M; Dasgupta J; Pasha QM
    Diabetes Technol Ther; 2014 Apr; 16(4):255-61. PubMed ID: 24625239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
    Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
    Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Lipoprotein-Associated Phospholipase A2 Level Is an Independent Predictor of High Thrombus Burden in Patients With Acute ST-segment Elevation Myocardial Infarction.
    Wu X; Zhang Y; Wu Z; You W; Liang F; Ye F; Chen S
    Int Heart J; 2016 Dec; 57(6):689-696. PubMed ID: 27818473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.